CymaBay Therapeutics, Inc.
Industry: Life Sciences ・ $CBAY on Nasdaq
Insider Sale
+$1,323,246
-27.47%
Shares
Shares Volume: 64,865 Shares
Average Share Price: $20.4
INSIDER
Shah Sujal
Chief Executive Officer (Director)
reported on Dec 11 2023
traded on Dec 11 2023
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 171,301 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,091,648.42 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 24 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $323,216.15 |
| COMPANY PREVIOUS TRADES |